Zum Inhalt

Optimizing disease risk stratification and clinical outcomes in chronic lymphocytic leukemia 2025

  • 01.05.2025
  • editorial
Erschienen in:

Auszug

A better understanding of disease biology and implementation of targeted agents have set a paradigm shift in motion in chronic lymphocytic leukemia (CLL) and rechallenged key principles in previous management strategies. In this issue of Magazine of European Medical Oncology (MEMO), we tackle three hot topics with novel clinical trial data and discuss their potential implications for clinical practice. …
Titel
Optimizing disease risk stratification and clinical outcomes in chronic lymphocytic leukemia 2025
Verfasst von
Jan-Paul Bohn
Publikationsdatum
01.05.2025
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 2/2025
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-025-01038-3
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.